Prader-willi syndrome:a clinical and epigenetic study of 4 cases

ZHANG Yuwen,HONG Jie,JIA Huiying,GE Yan,LI Xiaoying,NING Guang
2010-01-01
Abstract:Objective To study the molecular genetic defects and genomic imprinting basis of Chinese Prader-Willi syndrome(PWS) patients and to evaluate the clinical applications of a differential diagnostic test for PWS.Methods Fluorescence in situ hydbridiezation(FISH)and methylation-specific polymerase chain reaction (MS-PCR)techniques were applied for 4 clinically suspected PWS patients.Using SNRPN probe for identifying the critical locus in the PWS region,D15Z1 and PML control probes for identifying 5p arm and 15q arm,we detected the deletions of 15q in PWS.MS-PCR was performed using the CpGenome~(TM)Prader-Willi/Angelman Amplification Kit of Chemicon(Temecula,CA,USA).PCR products were obtained using either the M or the P primer sets (GenBank accession No.L 32702) after the bisulfite modification of genomic DNA.Results After hybridization with mixed probes,one patient was found to have an unbalanced de novo translocation 46,XX,t(7;15),while MS-PCR was normal.Bisulfite-modified DNA from the other 3 PWS patients amplified with methylated allele-specific primer pair showed only maternal 131bp PCR products,indicating the maternal uniparental disomy (UPD15).Conclusion Genomic imprinting plays an important role in the molecular pathogenesis of PWS caused by paternal microdeletions of 15q11-13 or maternal UPD of chromosome 15.The basic defect seems to be an absent function of PWS genes that are normally expressed only from the paternal chromosome 15.MS-PCR is a reliable diagnosis method for PWS patients who show abnormal methylation at SNRPN.The genetic differential tests for PWS are important in determining familial recurrence risk.
What problem does this paper attempt to address?